Endo Reports First Quarter 2016 Financial Results

Go back to Endo Reports First Quarter 2016 Financial Results

Guggenheim Cuts Price Target as Endo Int'l (ENDP) Cuts EPS Guidance

May 6, 2016 6:43 AM EDT

Guggenheim maintained a Buy rating on Endo International plc (NASDAQ: ENDP), and cut the price target to $35.00 (from $65.00), following the company's 1Q earnings report. ENDP reported an adjusted EPS of $1.08, $0.03 higher than consensus estimates. The company lowered its '16 EPS guidance from $5.85-6.20 to $4.50-4.80 midpoint... More

Endo Int'l (ENDP) Tops Q1 EPS by 4c, Guides FY Well Below Consensus

May 5, 2016 4:22 PM EDT

Endo Int'l (NASDAQ: ENDP) reported Q1 EPS of $1.08, $0.04 better than the analyst estimate of $1.04. Revenue for the quarter came in at $963.5 million versus the consensus estimate of $955.91 million.

GUIDANCE:

Endo Int'l sees FY2016 EPS of $4.50-$4.80, versus the consensus of... More